$BIIB Up to date company activities and other impo
Post# of 72747
Posted On: 02/06/2014 11:37:34 AM
$BIIB Up to date company activities and other important information about $BIIB
$BIIB
DD Notes ~ http://www.ddnotesmaker.com/BIIB
##### recent news/filings ~ source: finance.yahoo.com
Thu, 06 Feb 2014 13:50:04 GMT ~ Affymetrix Sees Turnaround Quarter but Earnings Miss
- The turnaround result was caused by increase in revenues and decrease in costs and expenses during the quarter.
read full: http://finance.yahoo.com/news/affymetrix-sees...04794.html
*********************************************************
Thu, 06 Feb 2014 13:15:28 GMT ~ Rethinking Risk Management: A New Approach To Portfolio Construction
- Rethinking Risk Management At its most basic, investing comprises two activities: buying securities we expect will generate decent returns, and limiting our risk in the event we are wrong.
read full: http://seekingalpha.com/article/1998811-rethi...urce=yahoo
*********************************************************
Thu, 06 Feb 2014 12:15:43 GMT ~ The Zacks Analyst Blog Highlights: Amgen, Biogen, Vertex, Celgene and Alexion
- The Zacks Analyst Blog Highlights: Amgen, Biogen, Vertex, Celgene and Alexion
read full: http://finance.yahoo.com/news/zacks-analyst-b...43304.html
*********************************************************
Wed, 05 Feb 2014 19:38:39 GMT ~ Brawl over Apple's cash gets public and heated
- As Apple's annual meeting approaches, some big investors are fighting an increasingly public fight over what the company should do with its cash.
read full: http://www.cnbc.com/id/101392753?__source=yah...27s+cash+g
*********************************************************
Wed, 05 Feb 2014 00:06:22 GMT ~ Novartis AG: Combating $2 Billion in Lost Sales
- Novartis (NVS) is taking heavy hits from the patent cliff, but Gilenya and Afinitor are two high growth bright spots.
read full: http://www.fool.com/investing/general/2014/02...lnk0000001
*********************************************************
##### chart ~ source: stockcharts.com
stockcharts.com/c-sc/sc?s=BIIB&p=D&b=5&g=0&id=p95448242713
##### chart ~ source: eoddata.com
http://chart.eoddata.com/?e=OTCBB&s=BIIB&...D&b=BB
##### company info ~ source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/BIIB/company-info
Ticker: $BIIB
OTC Market Place: Not Available
CIK code: 0000875045
Company name: Biogen Idec, Inc.
Company website: http://www.idecpharm.com
Incorporated In: DE, USA
##### extra dd links
Edgar filings: http://www.sec.gov/cgi-bin/browse-edgar?actio...p;count=40
Latest filings: http://www.otcmarkets.com/stock/BIIB/filings
Latest financials: http://www.otcmarkets.com/stock/BIIB/financials
Latest news: http://www.otcmarkets.com/stock/BIIB/news - http://finance.yahoo.com/q/h?s=BIIB+Headlines
Major holdings: http://data.cnbc.com/quotes/BIIB/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=BIIB+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/BIIB.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=BIIB
RegSho: http://www.regsho.com/tools/symbol_stats.php?...rch=search
DTCC: http://search2.dtcc.com/?q=Biogen+Idec%2C+Inc...ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&am...dec%2C+Inc.
Corporation WIKI: http://www.corporationwiki.com/search/results...=0&y=0
WHOIS: http://whois.domaintools.com/http://www.idecpharm.com
Alexa: http://www.alexa.com/siteinfo/http://www.idecpharm.com#
Corporate website internet archive: http://web.archive.org/web/*/http://www.idecpharm.com
http://www.pennystocktweets.com/stocks/profile/BIIB
##### last known share structure ~ source: otcmarkets.com
Market Value: $73,849,610,435 a/o Feb 05, 2014
Shares Outstanding: 236,212,930 a/o Oct 21, 2013
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.0005
##### business description ~ source: otcmarkets.com
IC
DD Notes ~ http://www.ddnotesmaker.com/BIIB
$BIIB
DD Notes ~ http://www.ddnotesmaker.com/BIIB
##### recent news/filings ~ source: finance.yahoo.com
Thu, 06 Feb 2014 13:50:04 GMT ~ Affymetrix Sees Turnaround Quarter but Earnings Miss
- The turnaround result was caused by increase in revenues and decrease in costs and expenses during the quarter.
read full: http://finance.yahoo.com/news/affymetrix-sees...04794.html
*********************************************************
Thu, 06 Feb 2014 13:15:28 GMT ~ Rethinking Risk Management: A New Approach To Portfolio Construction
- Rethinking Risk Management At its most basic, investing comprises two activities: buying securities we expect will generate decent returns, and limiting our risk in the event we are wrong.
read full: http://seekingalpha.com/article/1998811-rethi...urce=yahoo
*********************************************************
Thu, 06 Feb 2014 12:15:43 GMT ~ The Zacks Analyst Blog Highlights: Amgen, Biogen, Vertex, Celgene and Alexion
- The Zacks Analyst Blog Highlights: Amgen, Biogen, Vertex, Celgene and Alexion
read full: http://finance.yahoo.com/news/zacks-analyst-b...43304.html
*********************************************************
Wed, 05 Feb 2014 19:38:39 GMT ~ Brawl over Apple's cash gets public and heated
- As Apple's annual meeting approaches, some big investors are fighting an increasingly public fight over what the company should do with its cash.
read full: http://www.cnbc.com/id/101392753?__source=yah...27s+cash+g
*********************************************************
Wed, 05 Feb 2014 00:06:22 GMT ~ Novartis AG: Combating $2 Billion in Lost Sales
- Novartis (NVS) is taking heavy hits from the patent cliff, but Gilenya and Afinitor are two high growth bright spots.
read full: http://www.fool.com/investing/general/2014/02...lnk0000001
*********************************************************
##### chart ~ source: stockcharts.com
stockcharts.com/c-sc/sc?s=BIIB&p=D&b=5&g=0&id=p95448242713
##### chart ~ source: eoddata.com
http://chart.eoddata.com/?e=OTCBB&s=BIIB&...D&b=BB
##### company info ~ source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/BIIB/company-info
Ticker: $BIIB
OTC Market Place: Not Available
CIK code: 0000875045
Company name: Biogen Idec, Inc.
Company website: http://www.idecpharm.com
Incorporated In: DE, USA
##### extra dd links
Edgar filings: http://www.sec.gov/cgi-bin/browse-edgar?actio...p;count=40
Latest filings: http://www.otcmarkets.com/stock/BIIB/filings
Latest financials: http://www.otcmarkets.com/stock/BIIB/financials
Latest news: http://www.otcmarkets.com/stock/BIIB/news - http://finance.yahoo.com/q/h?s=BIIB+Headlines
Major holdings: http://data.cnbc.com/quotes/BIIB/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=BIIB+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/BIIB.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=BIIB
RegSho: http://www.regsho.com/tools/symbol_stats.php?...rch=search
DTCC: http://search2.dtcc.com/?q=Biogen+Idec%2C+Inc...ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&am...dec%2C+Inc.
Corporation WIKI: http://www.corporationwiki.com/search/results...=0&y=0
WHOIS: http://whois.domaintools.com/http://www.idecpharm.com
Alexa: http://www.alexa.com/siteinfo/http://www.idecpharm.com#
Corporate website internet archive: http://web.archive.org/web/*/http://www.idecpharm.com
http://www.pennystocktweets.com/stocks/profile/BIIB
##### last known share structure ~ source: otcmarkets.com
Market Value: $73,849,610,435 a/o Feb 05, 2014
Shares Outstanding: 236,212,930 a/o Oct 21, 2013
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.0005
##### business description ~ source: otcmarkets.com
IC
DD Notes ~ http://www.ddnotesmaker.com/BIIB
(0)
(0)